SEC Form 4 · accession 0001209191-15-042033
AMICUS THERAPEUTICS, INC. · FOLD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jay Barth
Officer — Chief Medical Officer
Period of report
May 8, 2015
Accepted (ET)
May 13, 2015 · 7:48 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001178879
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stockF1 | May 8, 2015 | M | 25,000 | — | A | 25,000 | D | |
| Common stock | May 8, 2015 | F | 9,313 | $10.80 | D | 15,687 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted stock unitsF1,F2 | — | May 8, 2015 | M | 25,000 | D | — | — | Common Stock | 25,000 | 25,000 | D |
Explanation of responses
- F1Restricted stock units convert into common stock on a one-for-one basis.
- F2On April 10, 2014, the reporting person was granted 50,000 restricted stock units, vesting in equal installments of 25,000 restricted stock units on May 10, 2015 and 25,000 restricted stock units on December 3, 2015.